Admune Therapeutics competitive analysis

Latest publications and patents of Admune Therapeutics New

Explore the latest publications and patents granted to Admune Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Admune Therapeutics

Jun 19, 2019Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha ComplexesGranted And Under Opposition
Oct 17, 2018Complexes Of Il-15 And Il-15R Alpha And Uses ThereofRevoked

Explore Admune Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 19, 2019Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes1
Oct 17, 2018Complexes Of Il-15 And Il-15R Alpha And Uses Thereof1

Latest PTAB cases involving Admune Therapeutics

Discover the latest PTAB cases involving Admune Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Admune Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ADMUNE THERAPEUTICS - 2 - - Non-Active
GRAF VON STOSCH3 - - - Highly Aggressive
HGF73 - - - Highly Aggressive